Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
15,247
datasets available to search
ShareScore release 0.9.0
Dataset results
15,247 results for “Breast cancer”
Palbociclib Plus Letrozole For Postmenopausal Women With HR(+) HER2(-) Advanced Breast Cancer For Whom Letrozole Is Deemed Appropriate
ClinicalTrials.gov study NCT02600923. IPD Sharing: YES. Countries: 4. Publications: 1.
Phase II Study of AZD2281 in Patients With Known BRCA Mutation Status or Recurrent High Grade Ovarian Cancer or Patients With Known BRCA Mutation Status/ Triple Neg Breast Cancer
ClinicalTrials.gov study NCT00679783. IPD Sharing: YES. Countries: 1. Publications: 3.
Use of Sentinel Lymph Node Biopsy in Patients With Early-Stage, Palpable Node-Positive HR+/HER2- Breast Cancer Having Upfront Surgery and Adjuvant Radiation
ClinicalTrials.gov study NCT04854005. IPD Sharing: YES. Countries: 1. Publications: 0.
The BEACON Study (Breast Cancer Outcomes With NKTR-102)
ClinicalTrials.gov study NCT01492101. IPD Sharing: Not stated. Countries: 11. Publications: 4.
A Study Assessing the Safety and Efficacy of Adding Ipatasertib to Paclitaxel Treatment in Participants With Breast Cancer That Has Spread Beyond the Initial Site, and the Cancer Does Not Have Certain
ClinicalTrials.gov study NCT02162719. IPD Sharing: YES. Countries: 8. Publications: 1.
Phase III to Evaluate Patient´s Preference of Subcutaneous Trastuzumab vs Intravenous in HER2+ Advanced Breast Cancer
ClinicalTrials.gov study NCT01875367. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Somatic Acupressure for Symptom Cluster Management in Breast Cancer Survivors
ClinicalTrials.gov study NCT06412107. IPD Sharing: NO. Countries: 1. Publications: 1.
Low-dose Oral Cyclophosphamide and Methotrexate Maintenance for Hormone Receptor-negative Early Breast Cancer
ClinicalTrials.gov study NCT00022516. IPD Sharing: Not stated. Countries: 11. Publications: 2.
A Study of Single-Agent Eribulin Mesylate as First-Line Therapy for Locally Recurrent or Metastatic Human Epidermal Growth Factor Receptor Two (HER2) Negative Breast Cancer
ClinicalTrials.gov study NCT01268150. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Hypofractionated Radiation Therapy or Standard Radiation Therapy in Treating Patients With Ductal Breast Carcinoma In Situ or Early Invasive Breast Cancer
ClinicalTrials.gov study NCT01266642. IPD Sharing: Not stated. Countries: 1. Publications: 3.
Liposomal Doxorubicin Before Mastectomy in Treating Women With Invasive Breast Cancer
ClinicalTrials.gov study NCT00290732. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Translating Research Into Practice: Patient Navigation for Breast Cancer
ClinicalTrials.gov study NCT03514433. IPD Sharing: NO. Countries: 1. Publications: 3.
Paclitaxel, Nab-paclitaxel, or Ixabepilone With or Without Bevacizumab in Treating Patients With Stage IIIC or Stage IV Breast Cancer
ClinicalTrials.gov study NCT00785291. IPD Sharing: Not stated. Countries: 2. Publications: 4.
AKT Inhibitor, Ipatasertib, With Endocrine and CDK 4/6 Inhibitor for Patients With Metastatic Breast Cancer (TAKTIC)
ClinicalTrials.gov study NCT03959891. IPD Sharing: YES. Countries: 1. Publications: 0.
Alternative Dosing Schedule of Palbociclib in Metastatic Hormone Receptor Positive Breast Cancer
ClinicalTrials.gov study NCT03007979. IPD Sharing: NO. Countries: 1. Publications: 1.
A Study of Trastuzumab Emtansine, Paclitaxel, and Pertuzumab in Patients With HER2-Positive, Locally Advanced or Metastatic Breast Cancer
ClinicalTrials.gov study NCT00951665. IPD Sharing: Not stated. Countries: 1. Publications: 1.
1st or 2nd Line MBC (Metastatic Breast Cancer) With Previous Avastin (Bevacizumab) Therapy
ClinicalTrials.gov study NCT00493636. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Nab-Paclitaxel and Atezolizumab Before Surgery in Treating Patients With Triple Negative Breast Cancer
ClinicalTrials.gov study NCT02530489. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Evaluation of an Anti-cancer Immunotherapy Combined With Standard Neoadjuvant Treatment in Patients With WT1-positive Primary Invasive Breast Cancer
ClinicalTrials.gov study NCT01220128. IPD Sharing: YES. Countries: 7. Publications: 1.
STRIDE - STimulating Immune Response In aDvanced brEast Cancer
ClinicalTrials.gov study NCT00925548. IPD Sharing: Not stated. Countries: 12. Publications: 1.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.